<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Matched related donor allo-SCT is the treatment of choice for patients with severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (SAA) younger than 40 years of age </plain></SENT>
<SENT sid="1" pm="."><plain>The standard conditioning regimen for such patients is <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> with antithymocyte globulin </plain></SENT>
<SENT sid="2" pm="."><plain>Unmanipulated BM is the best stem cell source for <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> patients going for SCT </plain></SENT>
<SENT sid="3" pm="."><plain>Post-transplant GVHD prophylaxis with <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> should be continued for 1 year </plain></SENT>
<SENT sid="4" pm="."><plain>Early graft failure is rare but potentially life-threatening complication of SCT that can be managed with salvage SCT using more intense conditioning regimen </plain></SENT>
</text></document>